Clinical Trial Update: αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT) [NA]

View source ↗

Summary

This clinical trial update notes a study exploring αβ T cell and CD19+ B cell depletion for alternative donor allogeneic hematopoietic cell transplantation, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Hematopoietic Stem Cell Transplantation, Hematologic Malignancy | NA | Status: RECRUITING